 |
Previous Article | Next Article 
Volume 17, Number 21,
Issue of November 1, 1997
pp. 8363-8375
Copyright ©1997 Society for Neuroscience
Glutamate Transporter Protein Subtypes Are Expressed
Differentially during Rat CNS Development
Akiko Furuta1,
Jeffrey D. Rothstein1, 2, and
Lee J. Martin2, 3
Departments of 1 Neurology,
2 Neuroscience, and 3 Pathology, Division of
Neuropathology, Johns Hopkins University School of Medicine, Baltimore,
Maryland 21287
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Extracellular glutamate concentrations are regulated by glial and
neuronal transporter proteins. Four glutamate transporter subtypes have
been identified in rat brain; GLAST and GLT-1 are primarily astrocytic,
whereas EAAC1 and EAAT4 are neuronal. Using immunoblotting and
immunohistochemistry with subtype-specific antipeptide antibodies, we
examined the protein expression and regional and cellular localization
of each glutamate transporter subtype in embryonic and postnatal rat
CNS. Each transporter had a specific pattern of expression. GLAST
immunoreactivity was low prenatally but became enriched in cerebellar
Bergmann glia early postnatally and then was also present in forebrain
later postnatally. The post-translational modification of GLAST was
unique among the subtypes; glycosylated GLAST increased with
maturation, whereas nonglycosylated protein decreased in abundance
postnatally. GLT-1 was present in fetal brain and spinal cord, with
expression progressively increasing to adult levels throughout the
neuraxis by postnatal day 26. Transient expression of GLT-1
immunoreactivity along axonal pathways was observed prenatally, in
contrast to the exclusive localization of GLT-1 to astrocytes in the
adult CNS. EAAC1, localized to neurons, was enriched in forebrain,
diencephalon, and hindbrain during prenatal and postnatal development.
EAAC1 expression was greater in newborn brain compared with adult
brain. EAAT4 had a region-specific distribution; EAAT4 was mainly in
cerebellum, localized to Purkinje cells, with much lower levels in
forebrain. EAAT4 levels increased in cerebellum with age. We conclude
that during CNS development the expression of glutamate transporter subtypes is differentially regulated, regionally segregated, and coordinated.
Key words:
brain development;
excitatory amino acid;
perinatal brain
damage;
corticogenesis;
excitotoxicity;
striatum
INTRODUCTION
Glutamate is the major excitatory
neurotransmitter in the mammalian CNS (Fonnum, 1984 ) and may also have
important roles in CNS development (MacDonald and Johnston, 1990 ;
Lauder, 1993 ). In vitro, glutamate has neurotrophic activity
(Brewer and Cotman, 1989 ), influences neuronal survival (Balazs et al.,
1988 ; Mount et al., 1993 ), and inhibits DNA synthesis in embryonic
cortex (LoTurco et al., 1995 ). Extracellular levels of glutamate are regulated by nonvesicular transporting proteins that reduce the concentration of glutamate at the synaptic cleft (Attwell et al., 1993 ), thereby preventing excessive stimulation of glutamate receptors that is neurotoxic (Choi et al., 1987 ; Rosenberg et al., 1992 ). To
date, four distinct high-affinity, sodium-dependent glutamate transporters have been cloned from animal and human tissue [GLAST (EAAT1), GLT-1 (EAAT2), EAAC1 (EAAT3), and EAAT4], and these proteins differ in structure, pharmacological properties, and tissue
distribution (Kanai and Hediger, 1992 ; Pines et al., 1992 ; Storck et
al., 1992 ; Kanai et al., 1993 , 1995 ; Arriza et al., 1994 ).
Immunohistochemical studies have revealed that GLAST and GLT-1 are
localized primarily in astrocytes (Rothstein et al., 1994 ; Chaudhry et
al., 1995 ; Lehre et al., 1995 ), whereas EAAC1 is widely distributed in
neurons (Rothstein et al., 1994 ). EAAT4, which also has properties of a
ligand-gated chloride channel (Fairman et al., 1995 ), is localized mainly in cerebellar Purkinje cells in rat and human CNS (Furuta et
al., 1997 ) and in mouse brain (Yamada et al., 1996 ).
Alterations in glutamate transporters occur in neurodegenerative
conditions that effect the adult and immature CNS. Specific glutamate
transporter proteins have been found to be downregulated in amyotrophic
lateral sclerosis (Rothstein et al., 1992 , 1995 ). In perinatal models
of hypoxia-ischemia, extracellular glutamate levels are increased
transiently (Hagberg et al., 1987 ; Gordon et al., 1991 ), possibly by
reversed glutamate transporter function (Szatkowski and Attwell, 1994 )
or defective uptake of glutamate (Silverstein et al., 1986 ). The
evolution of striatal neurodegeneration in hypoxic-ischemic newborns
is paralleled by abnormalities in glutamate transporters (Martin et
al., 1997a ). Other perinatal brain damage, such as periventricular
leukomalacia, may also be related to abnormalities in the metabolism or
regulation of glutamate, because oligodendrocytes from developing rat
brain in culture are highly vulnerable to glutamate toxicity (Oka et
al., 1993 ). However, the functions of the individual subtypes of
glutamate transporters and their cell type expression patterns during
normal CNS development remain to be clarified; furthermore, their
possible roles in perinatal brain damage are not fully understood.
In situ hybridization studies indicate that mRNA transcripts
for GLAST, GLT-1, and EAAC1 are expressed in subtype-specific patterns
during development of mouse brain (Shibata et al., 1996 ; Sutherland et
al., 1996 ). However, the relative abundance of these proteins and the
precise localizations of each glutamate transporter protein have not
been studied in developing rat brain. Therefore, we have used
immunoblotting and immunohistochemistry with subtype-specific antibodies to study the expression and distribution of GLAST, GLT-1,
EAAC1, and EAAT4 during rat CNS development.
MATERIALS AND METHODS
Antibodies. Four different subtype-specific
antipeptide antibodies to glutamate transporters were used in this
study. These rabbit polyclonal antibodies recognize distinct proteins
at ~65 kDa (GLAST; N-terminal), ~66 kDa (GLT-1; C-terminal), ~73
kDa (EAAC1; C-terminal), and ~66 kDa (EAAT4; C-terminal). The
generation and characterization of these antibodies have been described
previously (Rothstein et al., 1994 , 1995 ; Furuta et al., 1997 ).
Antibodies to synaptophysin (mouse, monoclonal; Boehringer Mannheim,
Indianapolis, IN) and GFAP (rabbit, polyclonal; Dakopatts, Copenhagen,
Denmark) were used as markers for synaptic maturation and astrocytes,
respectively.
Rat CNS tissue. All animal protocols were approved by the
Johns Hopkins University School of Medicine Animal Care and Use Committee. Rat embryos and postnatal pups were obtained from timed pregnant Sprague Dawley rats (Charles River Laboratories, Wilmington, MA). The day of birth was designated as postnatal day 0 (P0). Embryos
[embryonic day 15 (E15) and E18] were removed from anesthetized (4%
chloral hydrate) gravid rats by cesarean section. For postnatal studies, brain and spinal cord were obtained from rat pups anesthetized using hypothermia or 4% chloral hydrate.
Immunoblotting. Fresh frozen samples from rat cortex,
striatum, cerebellum, and spinal cord at P1, P5, P10, P16, P26, and adult were homogenized with a Brinkmann Polytron in 20 mM
Tris-HCl, pH 7.4, containing 10% sucrose, 50 U/ml Trasylol, 2 µg/ml
leupeptin, 5 µ/ml antipain, 1 µg/ml pepstatin A, 2.5 µg/ml
chymostatin, and (in mM): 0.1 phenylmethylsulfonyl
fluoride, 10 benzamidine, 1 EDTA, and 1 EGTA. These homogenates were
first centrifuged at 1000 × gav for 10 min. Then the supernatant was centrifuged at 114,000 × gav for 20 min. The resulting pellet was washed
in the same buffer three times by resuspension, followed by
centrifugation at 114,000 × gav for 20 min. The pellet was fully resuspended in this buffer supplemented with
20% glycerol. Protein concentrations were measured by a Coomassie
blue-based protein assay (Bio-Rad, Hercules, CA) with bovine serum
albumin as standard. Brain extracts were subjected to 10% SDS-PAGE and
transferred to nitrocellulose membrane by electroblotting. Blots were
blocked with 2.5% nonfat dry milk in PBS (0.1 M, pH 7.2)
and then incubated with primary antibody (0.2 µg/ml GLAST, 0.017 µg/ml GLT-1, 0.06 µg/ml EAAC1, 0.135 µg/ml EAAT4, and 2 ng/ml
synaptophysin) overnight at 4°C. After the primary antibody
incubation, membranes were washed and incubated with
peroxidase-conjugated secondary antibody (1:5000) and developed with
ECL (Amersham, Arlington Heights, IL). For deglycosylation experiments,
protein homogenates of adult and P10 striatum were digested with
N-glycosidase F (PNGase F) (0.6 U/ml; Bio-Rad) for 16 hr at
37°C, and then the samples were subjected to SDS-PAGE and
immunoblotting. Immunoreactive proteins were semiquantitatively evaluated by laser densitometry (Molecular Devices, Menlo Park, CA).
Immunohistochemistry. For light microscopy, embryonic rat
tissue at E15 and E18 was immersed in 4% paraformaldehyde in PBS. P1,
P5, P10, P16, and P24 rat pups and adults were perfused
intra-aortically with cold 0.1 M PBS followed by 4%
paraformaldehyde in PBS. Brain tissue was cryoprotected in 20%
glycerol and PBS and frozen in isopentane chilled by dry ice and cut
(40 µm) on a sliding microtome. After pretreating with 0.1 M periodate in Tris-buffered saline (TBS, pH 7.6) for 10 min and 1% borohydride in TBS for 10 min, sections were incubated
sequentially in 4% normal goat serum with 0.1% Triton X-100 in 0.05 M TBS for blocking, primary antibody (0.2 µg/ml GLAST,
0.17 µg/ml GLT-1, 0.06 µg/ml EAAC1, 0.135 µg/ml EAAT4, and GFAP
1:2000) with 2% normal goat serum in TBS for 48 hr at 4°C, secondary
antibody (biotinylated goat anti-rabbit IgG) diluted at 1:400 with 2%
normal goat serum in TBS, and then avidin-biotin complex diluted at
1:200 (Vector Laboratories, Burlingame, CA). Diaminobenzidine
tetrahydrochloride with H2O2 was used as the peroxidase substrate to visualize sites of antibody binding. For immunohistochemical controls, sections of developing rat brain were
incubated with transporter antibodies preabsorbed overnight with an
excess (50 µM) of homologous synthetic peptide
corresponding to the antigen used to generate the antipeptide
antibodies to the transporters, with normal rabbit IgG instead of
transporter antibodies, or with the primary or secondary antibody
omitted.
For electron microscopy, rats were perfused with 2% paraformaldehyde,
2% acrolein, and 0.1% glutaraldehyde in 0.1 M phosphate buffer. Brains were removed, rinsed in cold PBS, and cut (40 µm) on a
vibratome. After pretreatment with 1% sodium borohydride for 10 min,
vibratome sections were prepared for immunohistochemistry using the
same method for light microscopy, except that Triton X-100 was omitted.
Samples from these sections were osmicated, dehydrated by graded
concentrations of ethanol, and embedded to resin as described
(Rothstein et al., 1994 ). Ultrathin sections, stained with lead citrate
for 15 min, were viewed and photographed with a Hitachi H-600 electron
microscope.
RESULTS
Immunoblot analysis
Glutamate transporter antibodies detected distinct proteins with
molecular weights of 65-73 kDa in developing and adult rat CNS regions
(Fig. 1A). Apparent
homomultimers of GLAST, GLT-1, and EAAT4 were also observed. Aggregates
of GLAST and GLT-1 were found in neocortex, striatum (Fig.
1A), cerebellum, and spinal cord, whereas aggregates
of EAAT4 were found in cerebellum (Fig. 1A) but not
in neocortex, striatum, and spinal cord. These results are consistent
with cross-linking studies demonstrating that glutamate transporters
can form homomultimers (Haugeto et al., 1996 ). However, aggregates of
EAAC1 were not observed in neocortex, striatum (Fig. 1A), cerebellum, or spinal cord, thereby reflecting
differences among transporter subtype aggregation properties.
Fig. 1.
A, Immunoblots for glutamate
transporter subtypes and synaptophysin in developing rat striatum.
Adult cerebellar homogenate was loaded to the last lane of the EAAT4
blot. GLAST, GLT-1, and EAAT4 (lane with cerebellum) show dimerized
bands. Immunoblots for GLAST show a band at ~90 kDa that decreases
postnatally. A , This ~90 kDa band was not seen in
adult striatum under normal control conditions (left
lane) but appeared after deglycosylation with PNGase F
treatment (right lane). B, Immunoblot
density (y-axis; arbitrary units) for each
glutamate transporter subtype and synaptophysin in different CNS
regions during postnatal maturation. Each lane was loaded with 10 µg
of protein. B, Solid circle, cortex;
open circle, striatum; solid triangle,
cerebellum; open triangle, spinal cord. P1, P5,
P10, P16, and P26, Postnatal days;
CBM, cerebellum; Adult Cont, adult
control.
[View Larger Version of this Image (40K GIF file)]
During postnatal development, the regional expression of glutamate
transporter protein was different for each subtype (Fig. 1A,B). Early postnatally and in adulthood, GLAST was
most abundant in cerebellum and neocortex. GLAST expression increased
with age to reach adult levels near P26 in cerebellum, neocortex, and
striatum. An immunoreactive band at ~90 kDa was detected in striatum
(Fig. 1A), neocortex, cerebellum, and spinal cord
with GLAST antibodies. With postnatal maturation, the intensity of this
~90 kDa band decreased. Immunoreactive proteins with a comparable
Mr were detected in adult striatum protein
homogenates after PNGase F treatment (Fig. 1A ). A
nonglycosylated band at ~45 kDa was also detected after PNGase F
treatment in striatal homogenates from P10 (data not shown) and adult
rat (Fig. 1A ) but was not detected in developing striatum under normal, undigested conditions (Fig.
1A). The cross-reactivities of all of theses bands
were completely abolished when GLAST antibodies were preabsorbed with
50 µM synthetic GLAST peptide before immunoblotting of
P10 striatum (data not shown).
Near birth GLT-1 protein levels were highest in spinal cord and were
relatively low in cerebellum, striatum, and cortex (Fig. 1B). GLT-1 levels increased dramatically with brain
maturation, notably in striatum (Fig. 1A). EAAC1
expression was greater in immature brain than in mature brain (Fig. 1).
EAAC1 expression increased with maturation, reaching maximum levels
around P5-P16, and then decreased thereafter. EAAT4 had a highly
region-specific expression pattern. EAAT4 was abundant in cerebellum
(Fig. 1B). EAAT4 increased with maturation and
reached a maximum level at P26 in cerebellum. In contrast, only small
amounts of EAAT4 protein were detected in neocortex, striatum, and
spinal cord, reaching maximum levels around P10-P16 and then
decreasing with age (Fig. 1B).
During the same time course for glutamate transporter expression,
synaptophysin expression increased progressively with age in striatum,
neocortex, and cerebellum, although synaptophysin levels were
relatively constant in spinal cord with postnatal maturation (Fig.
1).
Distribution of glutamate transporter subtypes in fetal and
postnatal CNS
The localizations of each glutamate transporter subtype were
regionally differential during CNS development (Table
1, Figs. 2,
3). Brain sections used for immunohistochemical controls, including anti-GLAST, anti-GLT-1, anti-EAAC1, and anti-EAAT4 antibodies preabsorbed against their respective synthetic peptide, normal rabbit
IgG at comparable dilutions, and omission of primary and secondary
antibodies, were devoid of specific immunolabeling (data not shown).
Prenatally, GLT-1 and EAAC1 were abundant in brain and spinal cord,
whereas the levels of GLAST and EAAT4 were very low (Fig.
2A-D). EAAC1 was also present in some systemic
organs (e.g., liver and intestine) in fetal rat (Fig. 2C).
At E18, GLT-1 immunoreactivity was highly enriched in globus pallidus,
amygdala, perirhinal cortex, and lateral hypothalamus but was
moderately enriched in hippocampus and relatively low in the lateral
ganglionic eminence, striatum, thalamus, and neocortex (Fig.
3A). GLT-1 immunoreactivity was also found in white matter in fetal brain, notably in the optic
tract, fimbria, and stria terminalis, as well as in axonal pathways
interconnecting neocortex, basal ganglia, and thalamus (Fig.
3A). In contrast, EAAC1 in E18 rat brain was highly enriched throughout forebrain (including neocortex, perirhinal cortex, hippocampus, amygdala, and striatum) and in the thalamic reticular nucleus (Fig. 3B).
Fig. 2.
Dark-field photographs of immunoreactivity for
GLAST (A, E, I, M), GLT-1 (B, F, J,
N), EAAC1 (C, G, K, O), and EAAT4
(D, H, L, P) in rat sagittal sections at E18
(A-D), P1 (E-H), P10
(I-L), and P24 (M-P). The
expression of glutamate transporter subtypes was differentially
regulated during CNS development. nc, Neocortex; t, tectum; cbm, cerebellum;
m, medulla oblongata; ob, olfactory bulb;
s, septum; h, hippocampus;
th, thalamus; st, striatum;
drg, dorsal root ganglion; sc, spinal
cord. Scale bar, 5 mm.
[View Larger Version of this Image (97K GIF file)]
Fig. 3.
GLT-1 (A) and EAAC1
(B) immunoreactivity in rat forebrain at E18.
GLT-1 was expressed in the amygdala, perirhinal cortex, hippocampus,
fimbria, and optic nerve; however, sparse immunoreactivity was seen in
embryonic neocortex and striatum. GLT-1 immunoreactivity was also seen
along white matter pathways interconnecting neocortex, basal ganglia,
and thalamus (arrowheads). In contrast, strong EAAC1
immunoreactivity was seen in neocortex, striatum, hippocampus, and
reticular thalamic nucleus but not in the fimbria and optic nerve.
aa, Anterior cortical amygdaloid nucleus;
ff, fimbria fornix; ge, ganglionic
eminence; gp, globus pallidus; hi,
hippocampus; hy, hypothalamus; nc,
neocortex; oc, optic chiasm; pr,
perirhinal cortex; rt, reticular thalamic nucleus;
st, striatum; t, thalamus. Scale bar, 1 mm.
[View Larger Version of this Image (112K GIF file)]
Prominent changes in glutamate transporter localization occurred
postnatally and are best illustrated in sagittal sections of P1, P10,
and P24 rat (Fig. 2E-P). The pattern of expression during postnatal maturation for each glutamate transporter subtype was
distinct. GLAST immunoreactivity was low throughout the neuraxis at P1
and then increased in cerebellum and then in forebrain with maturation
(Fig. 2E,I,M). GLT-1 immunoreactivity was high
in medulla and olfactory bulb at P1, increased throughout brainstem and
forebrain by P10, and then became enriched in cerebellum after P10
(Fig. 2F,J,N). EAAC1 immunoreactivity was
present at moderate to high levels in neocortex, hippocampus, and
brainstem at P1, further increased in enrichment throughout the
neuraxis by P10, and then decreased by P24 (Fig. 2G,K,O).
EAAT4 immunoreactivity was selectively enriched in the posterior
cerebellar lobules at P1 and further increased in anterior cerebellum
and also became expressed at low levels in forebrain and thalamus by
P10 and then by P24 was uniformly enriched in cerebellar cortex but was
expressed at low levels in neocortex, striatum, hippocampus, and
thalamus (Fig. 2H,L,P). Each glutamate transporter
subtype showed an adult pattern of localization by P24 (Table 1, Fig.
2).
Regional localization of glutamate transporters
Neocortex
GLT-1 and EAAC1 were the prominent glutamate transporters in
developing neocortex (Fig. 4). At E15,
GLT-1 immunoreactivity was present in the marginal zone (i.e., layer I
or external plexiform layer) of the telencephalic vesicle and in the
subplate and intermediate zone at E18, with the latter pattern
dissipating with maturation (Fig. 4A). Early
postnatally and into adulthood, layer I was more enriched in GLT-1 than
other layers (Fig. 4A). Astrocytic cell bodies were
GLT-1 immunoreactive throughout the cortical layers at P10, and then
the neuropil became intensely immunoreactive by P24 (Fig.
4A). GLAST immunoreactivity had a profile similar to
that of GLT-1 in neocortex during postnatal maturation, although much
less prominent than GLT-1 (Fig. 2). In contrast, in the telencephalic vesicle at E15, EAAC1 was enriched in the marginal zone and was faintly
detected in the ventricular zone (Fig. 4B), and at
E18, intense EAAC1 immunoreactivity was seen throughout the neuropil of
the cortical plate, and scattered cell bodies were found in the
subplate and intermediate zone (Fig. 4B). At E18,
EAAC1 immunoreactivity was also present in the ganglionic eminence
(Fig. 3B). At P1, EAAC1-immunoreactive pyramidal cells were
detected in layers III, V, and VI (Fig. 4B). Neurons
in layer VI showed intense immunoreactivity at P10, and then by P24,
the neuropil and neuronal perikarya in all layers were intensely
immunoreactive for EAAC1 (Fig. 4B). In marked
contrast to EAAC1, only faint EAAT4 immunoreactivity was observed
during neocortical development (Fig. 2H,L,P) and in
adult neocortex (Table 1).
Fig. 4.
GLT-1 and EAAC1 immunoreactivity in the developing
cerebral neocortex. A, GLT-1 immunoreactivity in
cerebral cortex is low from E15 to P1, except in the marginal zone.
GLT-1 immunoreactivity is seen transiently in the subplate and
intermediate zone at P18. Postnatally, GLT-1 is expressed in astrocytic
cell bodies (P10) and then throughout the neuropil (astrocytic cell
processes) by P24. B, EAAC1 is enriched in marginal zone
at E15. Strong EAAC1 immunoreactivity is seen throughout the cortical
plate at E18 and is enriched in layer I, pyramidal cells of layer III,
and layer VI at P1. Neurons in layer VI show intense immunoreactivity at P10, and then pyramidal neurons throughout layer II to layer IV and
neuropil staining is seen at P24. vz, Ventricular zone; lv, lateral ventricle; cp, cortical
plate; sp, subplate; iz, intermediate zone; wm, white matter; I-VI, cortical
layers I-VI. Scale bar, 250 µm.
[View Larger Version of this Image (113K GIF file)]
Striatum and globus pallidus
In fetal rat, GLT-1 immunoreactivity was found in the medial
aspect of the ganglionic eminence (Fig. 3A) but was not
observed in striatum at E15 and E18 (other than in white matter
bundles), whereas GLT-1 was enriched in globus pallidus (Fig.
3A). During the first postnatal week, immunoelectron
microscopy showed that GLT-1 was expressed in astrocytic cell bodies
and processes in the striatum (Fig.
5A), but this pattern evolved
into a purely diffuse localization to astrocytic processes in the
neuropil by P24 (Fig. 5C) (Rothstein et al., 1994 ). As in
neocortex, GLT-1 was much more abundant than GLAST in developing
striatum. Faint immunoreactivity for GLAST was seen from E15 and
thereafter, and astrocytes were moderately immunoreactive for GLAST at
P24. In contrast to the astroglial glutamate transporters, EAAC1 in
fetal brain was highly enriched in both striatum and globus pallidus (Fig. 3B) and was the predominant neuronal glutamate
transporter in striatum compared with EAAT4 (Figs. 1, 2). Early
postnatally, EAAC1 immunoreactivity was present at high levels in the
striatal neuropil, corresponding to immunoreactive dendrites by
immunoelectron microscopy (Fig. 5B). By P24, medium-sized
principal neurons of the striatum and the neuropil were
EAAC1-immunoreactive, but the intensity of immunoreactivity at P24 was
lighter than during the first postnatal week (Fig. 5), consistent with
the developmental down-regulation seen by immunoblotting (Fig.
1A).
Fig. 5.
Patterns of GLT-1 (A, C) and EAAC1
(B, D) immunoreactivity within the striatum at P5 and
P24 (C, D) were different. GLT-1 immunoreactivity was
mainly seen in astrocytic cell bodies at P5 (A),
and then diffuse neuropil staining of astrocytic processes around
neurons was seen at P24 (C). In contrast, EAAC1
was diffusely expressed in striatum at P5 (B) and
then localized to medium-sized neurons at P24
(D). Immunoelectron microscopy showed GLT-1
immunoreactivity in astrocytic process (A, inset,
arrowheads) and EAAC1 immunoreactivity in dendrites (B,
inset, d) at P5. Arrowheads in B,
inset, Postsynaptic density; d, dendrite;
t, terminal. Scale bar: A-D, 50 µm;
A, inset, 760 nm; B, inset, 460 nm.
[View Larger Version of this Image (134K GIF file)]
Hippocampus
During embryogenesis, GLT-1 immunoreactivity was present in the
gray matter of the subiculum, CA1, CA3, and dentate gyrus and was
highly enriched in the fimbria (Fig. 3A). Prenatally, EAAC1
was highly enriched throughout the hippocampal formation gray matter
but was not detected in the fimbria (Fig. 3B). GLAST and
EAAT4 immunoreactivities were very faint to undetectable in fetal
hippocampal formation. During postnatal development of hippocampus, both GLT-1 and EAAC1 immunoreactivities were more enriched than GLAST
and EAAT4 immunoreactivities (see Figs. 2, 6). The localizations of
GLT-1 and EAAC1 were in part complementary during early postnatal maturation of hippocampus. At P1 and P10, GLT-1 was enriched in the
neuropil of the stratum oriens, stratum radiatum, and stratum lacuosum-moleculare of CA1 and CA3 and in the molecular and
infragranular layers of the dentate gyrus, but the pyramidal and
granule cell body layers had comparatively low GLT-1 immunoreactivity
(Fig. 6A,C). EAAC1
immunoreactivity, in contrast, was prominent in the pyramidal cell body
layers of CA1 and CA3 and in the granule cells of dentate gyrus at P10.
Although EAAC1 was also present in the neuropil of the stratum
oriens, stratum radiatum, and stratum lacuosum-moleculare of CA1 and
CA3 and in the molecular layer of the dentate gyrus, EAAC1 was notably
low in the infragranular layer at P10 (Fig. 6B,D). By
P24, both GLT1 and EAAC1 were localized throughout the hippocampus,
with both transporters highly enriched in the molecular layer of the
infrapyramidal blade of the dentate gyrus (Fig.
6E,F).
Fig. 6.
Immunoreactivity for GLT-1 (A, C,
E) and EAAC1 (B, D, F) in parasagittal
sections of hippocampus at P1 (A, B), P10 (C,
D), and P24 (E, F). GLT-1 and EAAC1
immunoreactivities were seen throughout development and into adulthood.
Postnatally, GLT-1 was localized in astrocytes. EAAC1 was seen in
neurons and was more enriched in pyramidal and granule cells at P10
(D). CA1 and CA3,
Cornu Ammon's subfields 1 and 3; dg, dentate gyrus;
H, hilus; o, stratum oriens;
p, stratum pyramidale; r, stratum
radiatum; lm, stratum lacuosum-moleculare;
m, molecular layer; g, granular layer.
Scale bar, 500 µm.
[View Larger Version of this Image (195K GIF file)]
Cerebellum
The cellular specificity in the expression of subtypes of
glutamate transporters was uniquely observed in the developing rat cerebellar cortex (Fig. 7). At P1 and P5,
specific immunorectivity for GLAST or GLT-1 was not observed in the
external granular layer (Fig. 7). At P5, some cells in the Purkinje
cell layer expressed GLT-1 immunoreactivity (Fig. 7F)
and likely corresponded to maturing Bergmann glia, because Bergmann
glial cell bodies and radial processes were distinctly immunoreactive
for GLT-1 and GLAST by P10 (Fig. 7I,J). Subsets of
cells in the internal granular layer were faintly immunoreactive for
GLAST or GLT-1 at P5 and P10 (Fig. 7F,I). By P24, the
neuropil of the molecular layer contained intense GLAST and GLT-1
immunoreactivity, and immunoreactive glial sheaths surrounded unlabeled
Purkinje cell bodies (Fig. 7N). In contrast,
throughout maturation and in adulthood, Purkinje cell bodies and their
dendrites were intensely immunoreactive for EAAC1 and EAAT4 (Fig.
7C,D,G,H, K,L,O,P). The internal granular layer had
differential patterns of expression for EAAC1 and EAAT4 in immature and
mature cerebellum. As the external granular layer dissipated and as
dendritic shafts and spines of Purkinje cells matured, the neuropil of
the molecular layer became correspondingly more enriched in EAAC1 and
EAAT4. EAAC1 and EAAT4 localization revealed that the posterior lobules of cerebellar cortex mature earlier than anterior lobules.
Fig. 7.
Immunoreactivity for GLAST (A, E, I,
M), GLT-1 (B, F, J, N), EAAC1
(C, G, K, O), and EAAT4 (D, H, L, P) in
cerebellar cortex at P1 (A-D), P5
(E-H), P10 (I-L), and P24
(M-P). Subsets of cells, most likely developing
Bergmann glia, in the Purkinje cell layer at P5 show slight GLT-1
immunoreactivity. In P10 cerebellum, fine processes of Bergmann glia
are immunoreactive for GLAST and GLT-1. EAAC1 and EAAT4 are expressed
in Purkinje cells from P1. EAAT4 expression in Purkinje cells began in
the caudal part of the cerebellum. At P24, all four glutamate
transporter subtypes are abundant in the cerebellar cortex; GLAST and
GLT-1 are enriched in Bergmann glia and molecular layer, whereas EAAC1
and EAAT4 are expressed in Purkinje cells and molecular layer.
dcn, Deep cerebellar nucleus; ml,
molecular layer; gl, granular layer; egl
and igl, external and internal granular layers,
respectively; pl, Purkinje cell layer. Scale bar:
A-D (P1), 400 µm; E-P
(P5, P10, P24), 50 µm.
[View Larger Version of this Image (150K GIF file)]
Spinal cord
In embryonic spinal cord, GLT-1 and EAAC1 were the major glutamate
transporters, whereas GLAST and EAAT4 were expressed and low levels
(see Figs. 1B, 2, 8). The changes in the localization of GLT-1 (Fig. 8C,G,K,O,S) and
EAAC1 (Fig. 8D,H,L,P,T) are shown in
transverse sections of spinal cord; Nissl-stained sections are shown
for neuroanatomical orientation and regional compartmentation (Fig.
8A,E,I,M,Q), and GFAP-stained sections are shown for
an astrocyte phenotype marker (Fig. 8B,F,J,N,P).
Intense GLT-1 immunoreactivity was seen in the white matter and dorsal
horn at E15 and E18 (Fig. 8C,G), whereas GLT-1 was more
enriched in astrocytes of gray matter by P24 (Fig. 8S). GFAP
was initially expressed in the medioventral white matter of spinal cord
between E15 and E18 (Fig. 8B,F); however, GLT-1 immunoreactivity was seen before GFAP expression. The
localizations of GFAP and GLT-1 were similar after P10. EAAC1
immunoreactivity was present in dorsal root ganglia (Figs.
2C, 8D) and spinal cord gray matter from
E15 to adulthood (Fig. 8) and was enriched in both dorsal and ventral
horns in developing and adult spinal cord. During development and in
adults, motor neurons were immunoreactive for EAAC1 but not GLAST,
GLT-1, or EAAT4 (Fig. 8).
Fig. 8.
Cresyl violet staining (A, E, I, M,
Q) and immunoreactivity for GFAP (B, F, J, N,
R), GLT-1 (C, G, K, O, S), and EAAC1 (D, H, L, P, T) in cervical spinal cord at E15
(A-D), E18 (E-H), P1 (I-L), P10 (M-P), and P24
(Q-T). GFAP was expressed at E18 in the
medioventral white matter (F). Intense GLT-1
immunoreactivity was seen in white matter and dorsal horn at E15
(C) and E18 (G), although
GLT-1 was more expressed in astrocytes of gray matter after P10
(O, S). EAAC1 was localized in gray matter throughout embryonic to postnatal periods. d, Dorsal horn;
v, ventral horn; wm, white matter;
drg, dorsal root ganglion; dct, dorsal
corticospinal tract; lcn, lateral cervical nucleus.
Scale bar, 500 µm.
[View Larger Version of this Image (186K GIF file)]
DISCUSSION
The expression and localization of glutamate transporter protein
subtypes during embryonic and postnatal development of the rat CNS were
analyzed with subtype-specific antibodies to GLAST, GLT-1, EAAC1, and
EAAT4. The transporter subtype specificities of these antibodies have
been shown previously (Rothstein et al., 1994 ; Furuta et al., 1997 ).
Several general findings were derived from this study. We found that
the different molecular subtypes of glutamate transporters have very
distinct, but coordinated, regional patterns of expression during CNS
development, and that the cell type specificity in the expression of
distinct glutamate transporters subtypes is, for the most part, similar
in developing and adult CNS, except for a possible transient
localization of GLT-1 in axons in embryonic CNS. In addition, the
regulated expression of glutamate transporter subtypes appears to
segregate within different CNS regions. For example, the dominant
astroglial and neuronal glutamate transporters in cerebellum are
GLAST and EAAT4, respectively, whereas GLT-1 and EAAC1 are the primary
astroglial and neuronal glutamate transporters, respectively, in
forebrain, brainstem, and spinal cord.
Comparison of glutamate transporter protein and mRNA
distributions in developing CNS
Many similarities are found when comparing our data on the
regional expression and localization of glutamate transporter proteins in developing rat CNS to results on glutamate transporter mRNA localization in developing mouse CNS; however, some differences are
present as well (Shibata et al., 1996 ; Sutherland et al., 1996 ). GLAST
(EAAT1) protein and mRNA are present predominantly in cerebellum early
postnatally and are both present at high levels in adult cerebellum
(Shibata et al., 1996 ; Sutherland et al., 1996 ); however, GLAST protein
levels increase postnatally in forebrain as well, whereas GLAST mRNA
levels are relatively constant in forebrain postnatally (Sutherland et
al., 1996 ). In contrast, GLT-1 (EAAT2) protein and mRNA levels both
increase throughout the neuraxis postnatally (Shibata et al., 1996 ;
Sutherland et al., 1996 ). Both GLAST and GLT-1 mRNA have been detected
in white matter in embryonic CNS (Sutherland et al., 1996 ). We have
found that expression of GLT-1 protein (but not GLAST protein) is very prominent in some white matter tracts in fetal rat CNS (Figs. 3A, 4A, 8C,G,K) and
fetal ovine brain (Northington et al., 1997 ). With regard to cellular
localization of glutamate transporter mRNA in developing mouse, GLAST
mRNA was found in cortical plate neurons; transcripts for GLAST and
GLT-1 were detected in dentate gyrus granule cells early postnatally;
GLT-1 mRNA was found in CA3 stratum pyramidale neurons; and GLAST mRNA
was observed in some Purkinje cells (Sutherland et al., 1996 ). In
developing rat CNS, we did not detect GLAST or GLT-1 immunoreactivity
in the cell bodies of these neuronal populations. Yet, in fetal ovine brain, we have detected, with the same antibodies used here, GLT-1 immunoreactivity in neuronal subsets in the subplate, the Purkinje cell
layer, and some cranial nerve motor nuclei, whereas in near-term brain,
a purely astroglial localization is observed, and by immunoblotting this antibody is highly specific for GLT-1 in fetal sheep brain (Northington et al., 1997 ). Thus, it seems possible that species differences exist in the cellular expression of some glutamate transporters during CNS development, but the functional relevance of
this possibility remains unclear.
Glutamate transporter expression during morphogenesis
The embryonic neocortex in vertebrates consists of the
ventricular, subventricular, intermediate, and marginal zones
(Jacobson, 1991 ), with radial glia and early postmitotic pyramidal
neurons anchoring to the marginal zone by their distal processes or
apical dendrites (Marín-Padilla, 1992 ). Stratification of
cerebral cortex is completed postnatally in rat (Jacobson, 1991 ).
During corticogenesis, EAAC1 was highly enriched in the marginal zone,
although GLT-1 and GLAST were only faintly to moderately detected.
Furthermore, perinatally, EAAC1 was more enriched than GLAST, GLT-1,
and EAAT4 in cerebral cortex. Thus, during corticogenesis at late
embryonic and early postnatal periods, glutamate transport by neurons,
specifically via EAAC1, may predominate over astroglial transport of
glutamate. Expression of EAAC1 at high levels in the external plexiform
layer appears to coincide with the maturation of the apical dendritic bouquets of pyramidal neurons (Marín-Padilla, 1992 ) at a time when non-NMDA glutamate receptors are also highly enriched in the
marginal zone (Furuta et al., 1995 ; Herrmann, 1996 ; Martin et al.,
1997b ).
Glutamatergic mechanisms are operative in undifferentiated
proliferative zones during embryogenesis. Glutamate activates non-NMDA glutamate receptors in the ventricular zone (LoTurco et al., 1995 ), and
AMPA receptor protein is expressed in proliferative zones in developing
ferret (Herrmann, 1996 ), rat (Martin et al., 1997b ), and ovine brain
(Furuta et al., 1995 ). GLAST and GLT-1 mRNAs are expressed in the
ventricular zone of embryonic mouse brain (Shibata et al., 1996 ;
Sutherland et al., 1996 ); although, at low levels, we found GLAST
immunoreactivity in the ventricular and subventricular zones of the
telencephalon and GLT-l and EAAC1 immunoreactivities in the ganglionic
eminence. Subsets of progenitor cells may therefore have an uncommitted
glutamate transporter phenotype, with cell type specificity for
glutamate transporter phenotype occurring with differentiation.
Coordinated expression of EAAC1 and GLT-1 in
neonatal brain
We found that EAAC1 protein expression was greater in newborn
brain compared with the level in adult brain. Furthermore, EAAC1 was
enriched in striatum at a time when GLT-1 immunoreactivity was
relatively low and when synaptic maturity (as determined by synaptophysin levels) was incomplete. This observation may reflect an
initial phase of excessive outgrowth of dendritic branches followed by
a pruning of redundant dendrites (Jacobson, 1991 ). Alternatively, these
findings may signify a coordinated expression of glutamate transporter
subtypes with synaptic maturation. Thus, in immature forebrain, when
mature synaptic patterns have not yet been established, glutamate
transport by neurons may be dominant, whereas astroglial glutamate
transport may predominate in mature forebrain at a time when synaptic
innervation is fully developed. This idea is consistent with the
finding that GLT-1 is induced in undifferentiated astrocytes by the
presence of neurons in vitro (Swanson et al., 1997 ). In
addition, GLT-1 and GLAST, but not EAAC1, are mainly responsible for
in vivo regulation of extracellular glutamate in adult brain
(Rothstein et al., 1996 ), consistent with the finding that GLT-1
expression is transiently reduced in adult striatum after
corticostriatal deafferentation (Ginsberg et al., 1995 ). Finally, EAAC1
may serve metabolic functions for neurons, because it is widely
expressed outside the nervous system (Fig. 2c). For example,
it may provide glutamate for resynthesis of GABA in GABAergic
presynaptic terminals, where the protein has been localized (Rothstein
et al., 1994 ).
GLT-1 localization in white matter during
late embryogenesis
Transient expression of GLT-1 was observed in white matter tracts
in fetal brain and spinal cord. Several possibilities may account for
this observation. GLT-1 in embryonic white matter may be in astroglia;
however, in spinal cord white matter, GLT-1 enrichment preceded the
enrichment of GFAP. GLT-1 may be localized in myelin sheaths of
developing oligodendroglia that closely contact growing axons; however,
oligodendrocytes first appear at P0 in rat optic nerve (Miller et al.,
1985 ), although we found the optic tract enriched in GLT-1 at E18.
Alternatively, although GLT-1 is primarily astroglial in adult rat
brain (Rothstein et al., 1994 ; Chaudhry et al., 1995 ; Lehre et al.,
1995 ), in fetal rat brain, GLT-1 protein may also be expressed in
neurons at levels in the cell body that are below the limits of
immunological detection, but at levels sufficient for detection in
growing axons. This latter possibility is supported by in
situ studies showing GLT-1 mRNA in hippocampal neurons in adult
(Torp et al., 1994 ; Lehre et al., 1996; Schmitt et al., 1996 ) and
developing (Sutherland et al., 1996 ) brain and by immunocytochemical
studies showing a transient expression of GLT-1 protein in neuronal
cell bodies and axons in fetal ovine brain (Northington et al.,
1997 ).
Differential post-translational modification of GLAST
during CNS development
Neurotransmitter transporter proteins generally contain multiple
consensus sites for N-linked glycosylation in the large extracellular loop (Patel, 1997 ). N-linked glycosylation of GLAST homomultimers may
be developmentally regulated. We detected a prominent ~90 kDa band
that may possibly correspond to a nonglycosylated dimerized species of
GLAST monomers (45 kDa). Alternatively, the 90 kDa species could
reflect a protein complex of a distinct developmentally regulated
protein that closely interacts with GLAST and thereby cross-reacts with
GLAST antibodies. Proteins that interact with glutamate transporter
subtypes have been suggested (Arriza et al., 1997 ). By immunoblotting,
the levels of this 90 kDa species decreased postnatally, whereas
glycosylated GLAST monomers and dimers increased with maturation.
Splice variants or truncated forms of GLAST have not been found by
Northern blot analysis using P10 striatum RNA (G. Lin, unpublished
observations). Developmental-dependent changes in glycosylation have
also been observed with dopamine transporters during postnatal
maturation (Patel et al., 1994 ). The developmental regulation in
glycosylation may be explained by the availability of different
glycosyltransferases during ontogenesis (Biol et al., 1987 ); yet, the
selectivity for this change in the post-translational modification of
GLAST (but not other glutamate transporters) is unclear. In
vitro studies have revealed that the extent of N-linked
glycosylation has a negligible effect on the transport activity of
GLAST expressed in Xenopus oocytes (Conradt et al., 1995 ).
However, the time course for the evolution of the adult pattern of
GLAST glycolysation appears to correspond roughly with the progressive
attainment of adult synaptophysin levels in the striatum; thus, the
post-translational processing of GLAST and synaptic innervation may
mature in parallel.
Conclusion
Expression of glial glutamate transporter GLAST and GLT-1
increased with brain maturation, whereas expression of neuronal glutamate transporter EAAC1 was greater in newborn compared with adult
brain. Expression of another neuronal glutamate transporter, EAAT4,
increased with maturation in cerebellum. Immunohistochemically, the
most dynamic changes were observed in a GLT-1 expression pattern. In
the embryonic stage at E18, transient expression of GLT-1 was seen in
white matter. Thus, the different subtypes of glutamate transporters
are expressed in regionally distinct patterns, with glial and neuronal
transporter expression appearing in a coordinated manner during CNS
development.
FOOTNOTES
Received May 27, 1997; revised Aug. 15, 1997; accepted Aug. 20, 1997.
This work was funded by National Institutes of Health National
Institute of Neurological Diseases and Stroke Grants NS33958, NS36465,
AG12992, and NS34100, the Muscular Dystrophy Association, The
Amyotrophic Lateral Sclerosis Association, and the Cal Ripken/Lou Gehrig Fund for Neuromuscular Research.
Correspondence should be addressed to Dr. Jeffrey D. Rothstein,
Department of Neurology, Johns Hopkins University School of Medicine,
Meyer 5-119, 600 North Wolfe Street, Baltimore, MD 21287-7519.
REFERENCES
-
Arriza JL,
Fairman WA,
Wadiche JI,
Murdoch GH,
Kavanaugh MP,
Amara SG
(1994)
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex.
J Neurosci
14:5559-5569[Abstract].
-
Arriza JL,
Eliasof S,
Kavanaugh MP,
Amara SG
(1997)
Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance.
Proc Natl Acad Sci USA
94:4155-4160[Abstract/Free Full Text].
-
Attwell D,
Babour B,
Szatkowski M
(1993)
Nonvesicular release of neurotransmitter.
Neuron
11:401-407[Web of Science][Medline].
-
Balazs R,
Jorgensen OS,
Hack N
(1988)
N-Methyl-D-aspartate promotes the survival of cerebellar granule cells in culture.
Neuroscience
27:437-451[Web of Science][Medline].
-
Biol MC,
Martin A,
Richard M,
Louisot P
(1987)
Developmental changes in intestinal glycosyl-transferase activities.
Pediatr Res
22:250-256[Web of Science][Medline].
-
Brewer GL,
Cotman CW
(1989)
NMDA receptor regulation of neuronal morphology in cultured hippocampal neurons.
Neurosci Lett
99:268-273[Web of Science][Medline].
-
Chaudhry FA,
Lehre KP,
van Lookeren Campagne M,
Ottersen OP,
Danbolt NC,
Storm-Mathisen J
(1995)
Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry.
Neuron
15:711-720[Web of Science][Medline].
-
Choi DW,
Maulucci-Gedde M,
Kriegstein AR
(1987)
Glutamate neurotoxicity in cortical cell culture.
J Neurosci
7:357-368[Abstract].
-
Conradt M,
Storck T,
Stoffel W
(1995)
Localization of N-glycosylation sites and functional role of the carbohydrate units of GLAST-1, a cloned rat brain L-glutamate/L-aspartate transporter.
Eur J Biochem
229:682-687[Web of Science][Medline].
-
Fairman WA,
Vandenberg RJ,
Arriza JL,
Kavanaugh MP,
Amara SG
(1995)
An excitatory amino-acid transporter with properties of a ligand-gated chloride channel.
Nature
375:599-603[Medline].
-
Fonnum F
(1984)
Glutamate: a neurotransmitter in mammalian brain.
J Neurochem
42:1-11[Web of Science][Medline].
-
Furuta A,
Blue ME,
Koehler RC,
Traystman RJ,
Martin LJ
(1995)
Expression of non-NMDA receptor subtypes is time- and laminar-dependent during corticogenesis.
Soc Neurosci Abstr
21:840.
-
Furuta A, Martin LJ, Lin C-L G, Dykes-Hoberg M, Rothstein
JD (1997) Cellular and synaptic localization of the neuronal
glutamate transporters EAAT3 and EAAT4. Neuroscience, in press.
-
Ginsberg SD,
Martin LJ,
Rothstein JD
(1995)
Regional deafferentation down-regulates subtypes of glutamate transporter proteins.
J Neurochem
65:2800-2803[Web of Science][Medline].
-
Gordon KE,
Simpson J,
Statman D,
Silverstein FS
(1991)
Effects of perinatal stroke on striatal amino acid efflux in rat studied with in vivo microdialysis.
Stroke
22:928-932[Abstract/Free Full Text].
-
Hagberg H,
Andersson P,
Kjellmer I,
Thiringer K,
Thordstein M
(1987)
Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia.
Neurosci Lett
78:311-317[Web of Science][Medline].
-
Haugeto Ø,
Ullensvang K,
Levy LM,
Chaudhry FA,
Honoré T,
Nielsen M,
Lehre KP,
Danbolt NC
(1996)
Brain glutamate transporter proteins form homomultimers.
J Biol Chem
271:27715-27722[Abstract/Free Full Text].
-
Herrmann K
(1996)
Differential distribution of AMPA receptors and glutamate during pre- and postnatal development in the visual cortex of ferrets.
J Comp Neurol
375:1-17[Web of Science][Medline].
-
Jacobson M
(1991)
In: Developmental neurobiology. New York: Plenum.
-
Kanai Y,
Hediger M
(1992)
Primary structure and functional characterization of a high affinity glutamate transporter.
Nature
360:467-471[Medline].
-
Kanai Y,
Smith CP,
Hediger MA
(1993)
A new family of neurotransmitter transporters: the high-affinity glutamate transporters.
FASEB J
7:1450-1459[Abstract].
-
Kanai Y,
Nussberger S,
Romero MF,
Boron WF,
Hebert SC,
Hediger MA
(1995)
Electrogenic properties of the epithelial and neuronal high-affinity glutamate transporter.
J Biol Chem
270:16561-16568[Abstract/Free Full Text].
-
Lauder JM
(1993)
Neurotransmitters as growth regulatory signals: role of receptors and second messengers.
Trends Neurosci
16:233-240[Web of Science][Medline].
-
Lehre KP,
Levy LM,
Ottersen OP,
Storm-Mathisen J,
Danbolt NC
(1995)
Differential expression of two glutamate transporters in rat brain: quantitative and immunocytochemical observations.
J Neurosci
15:1835-1853[Abstract].
-
LoTurco JJ,
Owens DF,
Heath MJS,
Davis MBE,
Kriegstein AR
(1995)
GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis.
Neuron
15:1287-1298[Web of Science][Medline].
-
MacDonald JW,
Johnston MV
(1990)
Physiological and pathophysiological roles and excitatory amino acids during central nervous system development.
Brain Res Rev
15:41-70[Medline].
-
Marín-Padilla M
(1992)
Ontogenesis of the pyramidal cell of the mammalian neocortex and developmental cytoarchitectonics: a unifying theory.
J Comp Neurol
321:223-240[Web of Science][Medline].
-
Martin LJ,
Brambrink AM,
Lehmann C,
Portera-Cailliau C,
Koehler R,
Rothstein J,
Traystman RJ
(1997a)
Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum.
Ann Neurol
42:335-348[Web of Science][Medline].
-
Martin LJ, Furuta A, Blackstone CD (1997b) AMPA receptor protein in
developing rat brain: GluR1 expression and localization change at
regional, cellular, and subcellular levels with maturation.
Neuroscience in press.
-
Miller RH,
David S,
Patel R,
Abney ER,
Raff MC
(1985)
A quantitative immunohistochemical study of macroglial cell development in the rat optic nerve: in vivo evidence for two distinct astrocyte lineages.
Dev Biol
111:35-41[Web of Science][Medline].
-
Mount HT,
Dreyfus CF,
Black IB
(1993)
Purkinje cell survival is differentially regulated by metabotropic and ionotropic excitatory amino acid receptors.
J Neurosci
13:3173-3179[Abstract].
-
Northington FJ, Traystman RJ, Koehler RC, Rothstein JD, Martin
LJ (1997) Regional and cellular expression of GLT1 and EAAC1
glutamate transporter proteins in ovine fetal brain. Neuroscience, in
press.
-
Oka A,
Belliveau MJ,
Rosenberg PA,
Volpe JJ
(1993)
Vulnerability of oligodendroglia to glutamate: pharmacology, mechanism, and prevention.
J Neurosci
13:1441-1453[Abstract].
-
Patel AP
(1997)
Neurotransmitter transporter proteins. Posttranslational modifications.
In: Neurotransmitter transporters: structure, function, and regulation (Reith MEA,
ed), pp 241-262. Totowa, NJ: Humana.
-
Patel AP,
Cerruti C,
Vaughan RA,
Kuhar MJ
(1994)
Developmentally regulated glycosylation of dopamine transporter.
Dev Brain Res
83:53-58[Medline].
-
Pines G,
Danbolt NC,
Bjørås M,
Zhang Y,
Bendahan A,
Eide L,
Koepsell H,
Storm-Mathisen J,
Seeberg E,
Kanner BI
(1992)
Cloning and expression of a rat brain L-glutamate transporter.
Nature
360:464-467[Medline].
-
Rosenberg PA,
Amin S,
Leitner M
(1992)
Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture.
J Neurosci
12:56-61[Abstract].
-
Rothstein JD,
Martin LJ,
Kuncl RW
(1992)
Decreased brain and spinal cord glutamate transport in amyotrophic lateral sclerosis.
N Engl J Med
326:1464-1468[Abstract].
-
Rothstein JD,
Martin L,
Levey AI,
Dykes-Hoberg M,
Jin L,
Wu D,
Nash N,
Kuncl RW
(1994)
Localization of neuronal and glial glutamate transporters.
Neuron
13:713-725[Web of Science][Medline].
-
Rothstein JD,
van Kammen M,
Levey AI,
Martin LJ,
Kuncl RW
(1995)
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.
Ann Neurol
38:73-84[Web of Science][Medline].
-
Rothstein JD,
Dykes-Hoberg M,
Pardo CA,
Bristol LA,
Jin L,
Kuncl RW,
Kanai Y,
Hediger MA,
Wang Y,
Schielke JP,
Welty DF
(1996)
Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.
Neuron
16:675-686[Web of Science][Medline].
-
Schmitt A,
Asan E,
Püschel B,
Jöns T,
Kugler P
(1996)
Expression of the glutamate transporter GLT1 in neural cells of the rat central nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry.
Neuroscience
71:989-1004[Web of Science][Medline].
-
Shibata T,
Watanabe M,
Tanaka K,
Wada K,
Inoue Y
(1996)
Dynamic changes in expression of glutamate transporter mRNAs in developing brain.
NeuroReport
7:705-709[Web of Science][Medline].
-
Silverstein FS,
Buchanan K,
Johnston MV
(1986)
Perinatal hypoxia-ischemia disrupts striatal high-affinity 3H-glutamate uptake into synaptosomes.
J Neurochem
47:1614-1619[Web of Science][Medline].
-
Storck T,
Schulte S,
Hofmann K,
Stoffel W
(1992)
Structure, expression, and functional analysis of a Na+-dependent glutamate/aspartate transporter from rat brain.
Proc Natl Acad Sci USA
89:10955-10959[Abstract/Free Full Text].
-
Sutherland ML,
Delaney TA,
Noebels JL
(1996)
Glutamate transporter mRNA expression in proliferative zones of the developing and adult murine CNS.
J Neurosci
16:2191-2207[Abstract/Free Full Text].
-
Swanson RA,
Liu J,
Miller JW,
Rothstein JD,
Farrell K,
Stein BA,
Longuemare MC
(1997)
Neuronal regulation of glutamate transporter subtype expression in astrocytes.
J Neurosci
17:932-940[Abstract/Free Full Text].
-
Szatkowski M,
Attwell D
(1994)
Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms.
Trends Neurosci
17:359-365[Web of Science][Medline].
-
Torp R,
Danbolt NC,
Babaie E,
Bjørås M,
Seeberg E,
Storm-Mathisen J,
Ottersen OP
(1994)
Differential expression of two glial glutamate transporters in the rat brain: an in situ hybridization study.
Eur J Neurosci
6:936-942[Web of Science][Medline].
-
Yamada K,
Watanabe M,
Shibata T,
Tanaka K,
Wada K,
Inoue Y
(1996)
EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses.
NeuroReport
7:2013-2017[Web of Science][Medline].
This article has been cited by other articles:

|
 |

|
 |
 
T. M. DeSilva, A. Y. Kabakov, P. E. Goldhoff, J. J. Volpe, and P. A. Rosenberg
Regulation of Glutamate Transport in Developing Rat Oligodendrocytes
J. Neurosci.,
June 17, 2009;
29(24):
7898 - 7908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nie and H.-R. Weng
Glutamate Transporters Prevent Excessive Activation of NMDA Receptors and Extrasynaptic Glutamate Spillover in the Spinal Dorsal Horn
J Neurophysiol,
April 1, 2009;
101(4):
2041 - 2051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Allene, A. Cattani, J. B. Ackman, P. Bonifazi, L. Aniksztejn, Y. Ben-Ari, and R. Cossart
Sequential Generation of Two Distinct Synapse-Driven Network Patterns in Developing Neocortex
J. Neurosci.,
November 26, 2008;
28(48):
12851 - 12863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Jelenkovic, M. D. Jovanovic, D. D. Stanimirovic, D. D. Bokonjic, G. G. Ocic, and B. S. Boskovic
Beneficial Effects of Ceftriaxone Against Pentylenetetrazole-Evoked Convulsions
Experimental Biology and Medicine,
November 1, 2008;
233(11):
1389 - 1394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Takasaki, R. Okada, A. Mitani, M. Fukaya, M. Yamasaki, Y. Fujihara, T. Shirakawa, K. Tanaka, and M. Watanabe
Glutamate Transporters Regulate Lesion-Induced Plasticity in the Developing Somatosensory Cortex
J. Neurosci.,
May 7, 2008;
28(19):
4995 - 5006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Murdoch and A. J. Roskams
A Novel Embryonic Nestin-Expressing Radial Glia-Like Progenitor Gives Rise to Zonally Restricted Olfactory and Vomeronasal Neurons
J. Neurosci.,
April 16, 2008;
28(16):
4271 - 4282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Cattani, V. D. Bonfardin, A. Represa, Y. Ben-Ari, and L. Aniksztejn
Generation of Slow Network Oscillations in the Developing Rat Hippocampus After Blockade of Glutamate Uptake
J Neurophysiol,
October 1, 2007;
98(4):
2324 - 2336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Regan, Y. H. Huang, Y. S. Kim, M. I. Dykes-Hoberg, L. Jin, A. M. Watkins, D. E. Bergles, and J. D. Rothstein
Variations in Promoter Activity Reveal a Differential Expression and Physiology of Glutamate Transporters by Glia in the Developing and Mature CNS
J. Neurosci.,
June 20, 2007;
27(25):
6607 - 6619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Schools, M. Zhou, and H. K. Kimelberg
Development of Gap Junctions in Hippocampal Astrocytes: Evidence That Whole Cell Electrophysiological Phenotype Is an Intrinsic Property of the Individual Cell
J Neurophysiol,
September 1, 2006;
96(3):
1383 - 1392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Feoli, I. Siqueira, L. M. V. Almeida, A. C. Tramontina, C. Battu, S. T. Wofchuk, C. Gottfried, M. L. Perry, and C.-A. Goncalves
Brain Glutathione Content and Glutamate Uptake Are Reduced in Rats Exposed to Pre- and Postnatal Protein Malnutrition
J. Nutr.,
September 1, 2006;
136(9):
2357 - 2361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhou, G. P. Schools, and H. K. Kimelberg
Development of GLAST(+) Astrocytes and NG2(+) Glia in Rat Hippocampus CA1: Mature Astrocytes Are Electrophysiologically Passive
J Neurophysiol,
January 1, 2006;
95(1):
134 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Dougherty, A. D. R. Garcia, I. Nakano, M. Livingstone, B. Norris, R. Polakiewicz, E. M. Wexler, M. V. Sofroniew, H. I. Kornblum, and D. H. Geschwind
PBK/TOPK, a Proliferating Neural Progenitor-Specific Mitogen-Activated Protein Kinase Kinase
J. Neurosci.,
November 16, 2005;
25(46):
10773 - 10785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zschocke, N. Bayatti, A. M. Clement, H. Witan, M. Figiel, J. Engele, and C. Behl
Differential Promotion of Glutamate Transporter Expression and Function by Glucocorticoids in Astrocytes from Various Brain Regions
J. Biol. Chem.,
October 14, 2005;
280(41):
34924 - 34932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hamann, D. J. Rossi, C. Mohr, A. L. Andrade, and D. Attwell
The electrical response of cerebellar Purkinje neurons to simulated ischaemia
Brain,
October 1, 2005;
128(10):
2408 - 2420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takayasu, M. Iino, W. Kakegawa, H. Maeno, K. Watase, K. Wada, D. Yanagihara, T. Miyazaki, O. Komine, M. Watanabe, et al.
Differential Roles of Glial and Neuronal Glutamate Transporters in Purkinje Cell Synapses
J. Neurosci.,
September 21, 2005;
25(38):
8788 - 8793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Diamond
Deriving the Glutamate Clearance Time Course from Transporter Currents in CA1 Hippocampal Astrocytes: Transmitter Uptake Gets Faster during Development
J. Neurosci.,
March 16, 2005;
25(11):
2906 - 2916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-X. Chen and S. N. Roper
Tonic Activity of Metabotropic Glutamate Receptors Is Involved in Developmental Modification of Short-Term Plasticity in the Neocortex
J Neurophysiol,
August 1, 2004;
92(2):
838 - 844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Huang and A. Bordey
Glial Glutamate Transporters Limit Spillover Activation of Presynaptic NMDA Receptors and Influence Synaptic Inhibition of Purkinje Neurons
J. Neurosci.,
June 23, 2004;
24(25):
5659 - 5669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Huang, S. R. Sinha, K. Tanaka, J. D. Rothstein, and D. E. Bergles
Astrocyte Glutamate Transporters Regulate Metabotropic Glutamate Receptor-Mediated Excitation of Hippocampal Interneurons
J. Neurosci.,
May 12, 2004;
24(19):
4551 - 4559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Brasnjo and T. S. Otis
Isolation of glutamate transport-coupled charge flux and estimation of glutamate uptake at the climbing fiber-Purkinje cell synapse
PNAS,
April 20, 2004;
101(16):
6273 - 6278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Demarque, N. Villeneuve, J.-B. Manent, H. Becq, A. Represa, Y. Ben-Ari, and L. Aniksztejn
Glutamate Transporters Prevent the Generation of Seizures in the Developing Rat Neocortex
J. Neurosci.,
March 31, 2004;
24(13):
3289 - 3294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Morita, K. Nakamura, M. Sawada, A. Shimada, K. Sato, H. Miyata, and E. Ohama
Inositol 1,4,5-Triphosphate Receptor Protein Immunohistochemistry of Cerebellar Purkinje Cells in Two Dogs with Hypoglycemia
Vet. Pathol.,
January 1, 2004;
41(1):
82 - 86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wakisaka, A. Furuta, K. Masuda, W. Morikawa, M. Kuwano, and T. Iwaki
Cellular Distribution of NDRG1 Protein in the Rat Kidney and Brain During Normal Postnatal Development
J. Histochem. Cytochem.,
November 1, 2003;
51(11):
1515 - 1525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Voutsinos-Porche, G. Knott, K. Tanaka, C. Quairiaux, E. Welker, and G. Bonvento
Glial Glutamate Transporters and Maturation of the Mouse Somatosensory Cortex
Cereb Cortex,
October 1, 2003;
13(10):
1110 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Palmer, H. Taschenberger, C. Hull, L. Tremere, and H. von Gersdorff
Synaptic Activation of Presynaptic Glutamate Transporter Currents in Nerve Terminals
J. Neurosci.,
June 15, 2003;
23(12):
4831 - 4841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tanaka, N. Maeda, M. Noda, and T. Marunouchi
A Chondroitin Sulfate Proteoglycan PTPzeta /RPTPbeta Regulates the Morphogenesis of Purkinje Cell Dendrites in the Developing Cerebellum
J. Neurosci.,
April 1, 2003;
23(7):
2804 - 2814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. G. Marshall and J. E. Goldman
Subpallial Dlx2-Expressing Cells Give Rise to Astrocytes and Oligodendrocytes in the Cerebral Cortex and White Matter
J. Neurosci.,
November 15, 2002;
22(22):
9821 - 9830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Barakat and A. Bordey
GAT-1 and Reversible GABA Transport in Bergmann Glia in Slices
J Neurophysiol,
September 1, 2002;
88(3):
1407 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikegaya, S. Matsuura, S. Ueno, A. Baba, M. K. Yamada, N. Nishiyama, and N. Matsuki
beta -Amyloid Enhances Glial Glutamate Uptake Activity and Attenuates Synaptic Efficacy
J. Biol. Chem.,
August 23, 2002;
277(35):
32180 - 32186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.M. Soria and M. Valdeolmillos
Receptor-activated Calcium Signals in Tangentially Migrating Cortical Cells
Cereb Cortex,
August 1, 2002;
12(8):
831 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-S. Yuan, L. Dey, J.-T. Xie, and H. H. Aung
Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling.
J. Pharmacol. Exp. Ther.,
April 1, 2002;
301(1):
1 - 6.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chen, C. Aoki, V. Mahadomrongkul, C. E. Gruber, G. J. Wang, R. Blitzblau, N. Irwin, and P. A. Rosenberg
Expression of a Variant Form of the Glutamate Transporter GLT1 in Neuronal Cultures and in Neurons and Astrocytes in the Rat Brain
J. Neurosci.,
March 15, 2002;
22(6):
2142 - 2152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuki, Y. Ikegaya, S. Matsuura, Y. Kanai, H. Endou, and N. Matsuki
Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes
J. Cell Sci.,
March 12, 2002;
114(20):
3717 - 3725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Proper, G. Hoogland, S. M. Kappen, G. H. Jansen, M. G. A. Rensen, L. H. Schrama, C. W. M. van Veelen, P. C. van Rijen, O. van Nieuwenhuizen, W. H. Gispen, et al.
Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy
Brain,
January 1, 2002;
125(1):
32 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhou and H. K. Kimelberg
Freshly Isolated Hippocampal CA1 Astrocytes Comprise Two Populations Differing in Glutamate Transporter and AMPA Receptor Expression
J. Neurosci.,
October 15, 2001;
21(20):
7901 - 7908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Smith, V. Haroutunian, K. L. Davis, and J. H. Meador-Woodruff
Expression of Excitatory Amino Acid Transporter Transcripts in the Thalamus of Subjects With Schizophrenia
Am J Psychiatry,
September 1, 2001;
158(9):
1393 - 1399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Vorwerk, R. Naskar, F. Schuettauf, K. Quinto, D. Zurakowski, G. Gochenauer, M. B. Robinson, S. A. Mackler, and E. B. Dreyer
Depression of Retinal Glutamate Transporter Function Leads to Elevated Intravitreal Glutamate Levels and Ganglion Cell Death
Invest. Ophthalmol. Vis. Sci.,
October 1, 2000;
41(11):
3615 - 3621.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Metin, J.-P. Denizot, and N. Ropert
Intermediate Zone Cells Express Calcium-Permeable AMPA Receptors and Establish Close Contact with Growing Axons
J. Neurosci.,
January 15, 2000;
20(2):
696 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kojima, T. Nakamura, T. Nidaira, K. Nakamura, N. Ooashi, E. Ito, K. Watase, K. Tanaka, K. Wada, Y. Kudo, et al.
Optical Detection of Synaptically Induced Glutamate Transport in Hippocampal Slices
J. Neurosci.,
April 1, 1999;
19(7):
2580 - 2588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Lehre and N. C. Danbolt
The Number of Glutamate Transporter Subtype Molecules at Glutamatergic Synapses: Chemical and Stereological Quantification in Young Adult Rat Brain
J. Neurosci.,
November 1, 1998;
18(21):
8751 - 8757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Bergles and C. E. Jahr
Glial Contribution to Glutamate Uptake at Schaffer Collateral-Commissural Synapses in the Hippocampus
J. Neurosci.,
October 1, 1998;
18(19):
7709 - 7716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamada, M. Watanabe, T. Shibata, M. Nagashima, K. Tanaka, and Y. Inoue
Glutamate Transporter GLT-1 Is Transiently Localized on Growing Axons of the Mouse Spinal Cord before Establishing Astrocytic Expression
J. Neurosci.,
August 1, 1998;
18(15):
5706 - 5713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mennerick, R. P. Dhond, A. Benz, W. Xu, J. D. Rothstein, N. C. Danbolt, K. E. Isenberg, and C. F. Zorumski
Neuronal Expression of the Glutamate Transporter GLT-1 in Hippocampal Microcultures
J. Neurosci.,
June 15, 1998;
18(12):
4490 - 4499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Schlag, J. R. Vondrasek, M. Munir, A. Kalandadze, O. A. Zelenaia, J. D. Rothstein, and M. B. Robinson
Regulation of the Glial Na+-Dependent Glutamate Transporters by Cyclic AMP Analogs and Neurons
Mol. Pharmacol.,
March 1, 1998;
53(3):
355 - 369.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Li, G. A. R. Mealing, P. Morley, and P. K. Stys
Novel Injury Mechanism in Anoxia and Trauma of Spinal Cord White Matter: Glutamate Release via Reverse Na+-dependent Glutamate Transport
J. Neurosci.,
July 15, 1999;
19(14):
RC16 - RC16.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|